Isovanillin

Isovanillin

SCHEMBL1936859

COc1ccc(C=O)cc1O.COc1ccc(C=O)cc1OS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.63
SMN1; SMN2 Q16637 4/20 0.63
MAPK1 P28482 2/20 0.63
ALDH1A1 P00352 14/20 0.61
AOX1 Q06278 1/20 0.61
GFER P55789 1/20 0.60
GAA P10253 2/20 0.58
MAPT P10636 6/20 0.54
LMNA P02545 5/20 0.54
PKM P14618 2/20 0.54
HTT P42858 3/20 0.54
APP P05067 1/20 0.52
TDP1 Q9NUW8 2/20 0.50
TSHR P16473 1/20 0.50
TRIM24 O15164 1/20 0.50
ALDH5A1 P51649 1/20 0.50
ABAT P80404 1/20 0.50
TRIM33 Q9UPN9 1/20 0.50
MEN1 O00255 6/20 0.49
KMT2A Q03164 6/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1935202 0.92 HPGD (0.67) HPGDSMN1; SMN2MAPK1ALDH1A1GFER
SCHEMBL1936658 0.87 GFER (0.72) HPGDSMN1; SMN2MAPK1ALDH1A1GFER
SCHEMBL9155140 0.86 GFER (0.61) HPGDSMN1; SMN2MAPK1ALDH1A1GFER
SCHEMBL21993216 0.82 GFER (0.58) HPGDSMN1; SMN2MAPK1ALDH1A1GFER
SCHEMBL15631695 0.79 GFER (0.53) HPGDSMN1; SMN2MAPK1ALDH1A1GFER
Isovanillin SCHEMBL1535672 0.78 ALDH1A1 (1.00) HPGDSMN1; SMN2ALDH1A1AOX1MAPT
Isovanillin SCHEMBL70256 0.78 ALDH1A1 (1.00) HPGDSMN1; SMN2ALDH1A1AOX1MAPT
Isovanillin SCHEMBL29396443 0.78 ALDH1A1 (1.00) HPGDSMN1; SMN2ALDH1A1AOX1MAPT
SCHEMBL222230 0.78 GFER (0.60) HPGDSMN1; SMN2MAPK1ALDH1A1GFER
SCHEMBL222229 0.78 GFER (0.60) HPGDSMN1; SMN2MAPK1ALDH1A1GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2331539-A2 1,3,4,6,7,11B-HEXAHYDRO-BENZO[ALPHA]QUINOLIZINES FOR THE TREATMENT OF HYPERKINETIC MOVEMENT AND RELATED DISORDERS Biovail Laboratories International (Barbados) SRL (BB) 2011-06-15 EP disclosed
WO-2010026436-A2 PHARMACEUTICAL COMPOUNDS BIOVAIL LABORATORIES INTERNATIONAL (BARBADOS) SRL (BB) 2010-03-11 WO disclosed